β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice
Abstract In patients with chronic kidney disease, skeletal muscle dysfunction is associated with mortality. Uremic sarcopenia is caused by ageing, malnutrition, and chronic inflammation, but the molecular mechanism and potential therapeutics have not been fully elucidated yet. We hypothesize that ac...
Guardado en:
Autores principales: | Takaaki Higashihara, Hiroshi Nishi, Koji Takemura, Hiroshi Watanabe, Toru Maruyama, Reiko Inagi, Tetsuhiro Tanaka, Masaomi Nangaku |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af447127c6a9429db2ebf8a6101e4af1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy.
por: Hyun-Jun Kim, et al.
Publicado: (2021) -
The β3 Adrenergic Receptor Agonist CL316243 Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats by Activating AMPK/PGC-1α Signaling in Skeletal Muscle
por: Ding LN, et al.
Publicado: (2021) -
Oral intake of rice overexpressing ubiquitin ligase inhibitory pentapeptide prevents atrophy in denervated skeletal muscle
por: Reiko Nakao, et al.
Publicado: (2021) -
Active acetylcholine receptors prevent the atrophy of skeletal muscles and favor reinnervation
por: Bruno A. Cisterna, et al.
Publicado: (2020) -
Predicting novel binding modes of agonists to β adrenergic receptors using all-atom molecular dynamics simulations.
por: Stefano Vanni, et al.
Publicado: (2011)